These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 13879389)

  • 41. MASS IMMUNISATION AGAINST POLIOMYELITIS IN CEYLON IN 1962 USING SABIN ORAL VACCINE.
    ARUMANAYAGAM P
    J Trop Med Hyg; 1965 May; 68():105-9. PubMed ID: 14287300
    [No Abstract]   [Full Text] [Related]  

  • 42. Sabin and Salk poliovirus vaccine: vice versa.
    Cohen HH
    Acta Leiden; 1987; 56():65-83. PubMed ID: 3329800
    [No Abstract]   [Full Text] [Related]  

  • 43. [RESULTS OF MASS IMMUNIZATION WITH LIVE POLIOMYELITIS VACCINE AND PROSPECTS OF ERADICATION OF THIS DISEASE].
    CHUMAKOV MP; VOROSHILOVA MK; DZAGUROV SG; DROZDOV SG; LASHKEVICH VA; MIRONOVA LL; RALF NM; SINIAK KM; BARTOSHEVICH EN; VASILEVA KA; GAGARINA AV; GRACHEV VP; ZHEVANDROVA VI; TARANOVA GP; KOROLEVA GA; KUKAIN RA; ROBINZON AI; TIUFANOV AV; ELBERT LB
    Vestn Akad Med Nauk SSSR; 1963; 18():5-15. PubMed ID: 14064657
    [No Abstract]   [Full Text] [Related]  

  • 44. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 45. The Sabin live poliovirus vaccination trials in the USSR, 1959.
    Horstmann DM
    Yale J Biol Med; 1991; 64(5):499-512. PubMed ID: 1814062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial.
    Liao G; Li R; Li C; Sun M; Li Y; Chu J; Jiang S; Li Q
    J Infect Dis; 2012 Jan; 205(2):237-43. PubMed ID: 22158682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between vaccine coverage against polio and circulation and genetic evolution of the poliovirus strains isolated in Romania in the framework of the global polio eradication strategy.
    Băicuş A; Persu A; Popescu M; Penciu A; Stavri S; Soare A; Grecu N; Szmal C; Oprişan G
    Roum Arch Microbiol Immunol; 2009; 68(3):145-50. PubMed ID: 20361534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Decision analysis in planning for a polio outbreak in the United States.
    Jenkins PC; Modlin JF
    Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [PRESENT STATE OF POLIOMYELITIS AFTER MASS VACCINATION WITH THE LIVE ATTENUATED SABIN TYPE VACCINE].
    HAMZA B; BENATTIA A
    Tunis Med; 1964; 42():579-97. PubMed ID: 14297198
    [No Abstract]   [Full Text] [Related]  

  • 52. Immunization against poliomyelitis: risk/benefit/cost in a changing context.
    Salk J
    Dev Biol Stand; 1979; 43():151-7. PubMed ID: 230106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees.
    Friedrich F
    Acta Virol; 1996 Jun; 40(3):157-70. PubMed ID: 8891097
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Killed (Salk type) or living (Sabin type) poliomyelitis vaccine?].
    VERLINDE JD
    Ned Tijdschr Geneeskd; 1962 Dec; 106():2599-604. PubMed ID: 13996794
    [No Abstract]   [Full Text] [Related]  

  • 55. [VACCINE-ASSOCIATED PARALYTIC POLIOMYELITIS IN RUSSIAN FEDERATION DURING THE PERIOD OF CHANGES IN VACCINATION SCHEDULE (2006-2013 yy.)].
    Ivanova OE; Eremeeva TP; Morozova NS; Shakaryan AK; Gmyl AP; Yakovenko ML; Korotkova EA; Chernjavskaja OP; Baykova OY; Silenova OV; Krasota AY; Krasnoproshina LI; Mustafina AN; Kozlovskaja LI
    Vopr Virusol; 2016; 61(1):9-15. PubMed ID: 27145594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Poliovirus vaccine, live, oral (Sabin). First field trial in India. I. Administration of the vaccine.
    GHARPURE PV; DAVE KH
    Indian J Med Sci; 1962 Jan; 16():1-27. PubMed ID: 13898175
    [No Abstract]   [Full Text] [Related]  

  • 57. Present status of immunization against poliomyelitis (Salk vaccine versus living, attenuated virus).
    WEISS C
    J Albert Einstein Med Cent (Phila); 1956 Sep; 4(4):159-60. PubMed ID: 13357446
    [No Abstract]   [Full Text] [Related]  

  • 58. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates.
    Kroiss SJ; Famulare M; Lyons H; McCarthy KA; Mercer LD; Chabot-Couture G
    Vaccine; 2017 Oct; 35(42):5674-5681. PubMed ID: 28890193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. II. Parallel vaccinations and cross-wise revaccination in school children with the Sabin and WM3 attenuated strains.
    Böttiger M
    J Pediatr; 1969 Aug; 75(2):273-80. PubMed ID: 4307564
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.